02652

CF PharmTech

15.760

+0.190+1.22%

Closed16:08 07/24 HKT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE16.080/15.700

TODAY RANGE16.080-20.260

VOL4.55M

MARKET CAP8.19B

52 WEEK RANGE14.820-48.800

AVG VOL (3M)705.58K

% TURNOVER1.10%

TURNOVER86.81M

P/E (TTM)2,965.672

% RANGE26.62%

EPS(TTM)0.007

P/E(FORWARD)--

P/B5.018

BVPS3.959

DIVIDEND--

P/S17.037

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP5.98B

SHARES OUTSTANDING411.98M

NEXT EARNINGS--

FREE FLOAT300.83M

LOT SIZE100

EX-DATE--

News

Press Releases

Financial Reports

Profile

PUBT·10h ago
CF PharmTech prices HK$ 300.55 million H-share placement at HK$ 13.82 each
PUBT·06/26 13:54
CF PharmTech elects new board, names Zhang Jingjing executive director
PUBT·06/16 11:08
CF Pharmtech files HKEX next-day disclosure return, reports share repurchase at HKD 18.17
PUBT·06/12 11:34
CF Pharmtech files HKEX next-day disclosure return reporting share buyback at HKD 17.98 each
PUBT·06/11 12:15
CF Pharmtech files HKEX next-day disclosure return on share buyback at HKD 18.28 average price
PUBT·06/09 12:08
CF Pharmtech files HKEX next-day disclosure return reporting share repurchase at HKD 19.14-high HKD 18.52-low
PUBT·05/29 14:13
CF Pharmtech files directors list with Hong Kong Stock Exchange
PUBT·05/29 14:09
CF PharmTech non-executive director Chen Penghui resigns effective May 29, 2026
PUBT·05/28 00:01
CF PharmTech submits CF017 inhalation drug marketing application in Southeast Asia
PUBT·05/26 00:01
CF PharmTech says NMPA accepts marketing application for tiotropium bromide inhalation powder
PUBT·05/20 10:28
CF Pharmtech files HKEX return disclosing share repurchase at HKD 20.22 each
PUBT·05/15 11:23
CF Pharmtech files HKEX next-day return disclosing share repurchase at HKD 20.67
PUBT·05/13 12:27
CF Pharmtech files HKEX return disclosing share buyback at HKD 20.88 per share
PUBT·05/11 12:21
CF Pharmtech files HKEX return disclosing share buyback at HKD 21.93 each
PUBT·05/08 10:33
CF Pharmtech files HKEX return disclosing share buyback at HKD 21.75 each

Same Industry

Name/Symbol

Change%

Price

Amgen

04332

0.00%

藥

藥明康德

02359

-0.69%

157.400

海

海螺創業

00586

-0.46%

8.740

凱

凱萊英

06821

+2.34%

118.200

國

國藥控股

01099

-0.53%

16.840

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

+1.93%

15.850

麗

麗珠醫藥

01513

-2.46%

25.360

上

上海醫藥

02607

-1.17%

11.800

復

復星醫藥

02196

-2.43%

16.070

康

康哲藥業

00867

-1.87%

12.090

06600

藥

藥明生物

02269

-0.36%

39.100

中

中國同輻

01763

-4.02%

16.460

02877

聯

聯邦制藥

03933

-0.44%

9.090

康

康臣葯業

01681

-0.67%

13.390

3SBio

01530

-1.65%

17.280

山

山東新華製藥股份

00719

+4.64%

6.310

同

同仁堂國藥

03613

-1.04%

6.680

華

華潤醫藥

03320

-2.06%

4.760

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English